The landscape of dementia analysis has advanced radically with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological improvements represent extraordinary progress in being familiar with neurodegenerative conditions, https://tomr752qai2.blogscribble.com/profile